Series A Therapeutics Companies

Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies.

SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.

ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.

Delphia Therapeutics operates and manages a laboratory that develops treatments for cancer cells.

YGION Biomedical is an Austrian biotechnology firm committed to making personalized cancer immunotherapy a reality.

Oorja Bio is is a clinical-stage biotechnology company focused on developing therapies.

Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.

Uniquity Bio is a clinical-stage drug development company focused on advancing scientific innovation and delivering novel medicines.

Initial Therapeutics is a developer of small-molecule medicines designed to prevent pathogenic protein synthesis.

A telehealth platform connecting patients whose mother tongue is not English with doctors who can speak their mother tongue.

Bone Health Technologies is developing a new standard of care for treating osteopenia, the precursor to osteoporosis.

Merida Biosciences is a biotech company focused on developing precision treatments, particularly for autoimmune diseases.

Summation Bio is a gene therapy company that develops a novel non-viral gene transfer technology.

D2M Biotherapeutics focuses on the development of novel immunotherapeutics.

Axoft is a revolutionary seamless interface between brain and machine.

Heartbeat collects the most important data point in healthcare: quality of life (PROMs) and turns it into Real World Evidence (RWE)

Kelonia Therapeutics develops genetic medicines focused on in vivo gene delivery and cell therapy for cancer and other diseases.

Fathom Therapeutics focuses on drug design by harnessing biomolecular motion to develop therapeutics that can reprogram protein function.

Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.

Pheast Therapeutics develops checkpoint therapies to harness the innate immune system.

Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

Biovitae focuses on infection control and prevention, as well as combating antimicrobial resistance.

Cyto-Facto is a biotechnology company that develops and manufactures CAR-T cell therapies and mesenchymal stem cell products.

Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.